Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...
You probably aren't drinking enough water, and Kohler's newest device tells you so -- from your toilet. Kohler unveiled Dekoda, a sensor that attaches to a toilet to monitor hydration, gut health, ...
ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...
Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...
The company’s sensor and other revenue, which represents 97% of total revenue, jumped 18% YoY to $1.12 billion, offsetting a 31% decline in hardware revenue. "During the quarter, Dexcom delivered ...
This is a Class I recall where 56 serious injuries have been reported. If you use one of Dexcom's continuous glucose monitoring systems, here's what you need to know. Taylor Leamey wrote about all ...
Medicare Part B typically covers continuous glucose monitors (CGMs) like the Dexcom G7, as they are Food and Drug Administration (FDA)-approved durable medical equipment items. To get a Dexcom G7 CGM ...
Monitoring your blood sugar levels is crucial for effective diabetes management. It helps you understand how different factors, such as diet and exercise, impact your blood sugar range. A healthy ...
An interdisciplinary team of researchers from various Chinese universities have developed a miniature-sized continuous glucose monitoring system that works as effectively as market-leading systems.
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
DexCom, Inc. DXCM is scheduled to release second-quarter 2024 results on Jul 25, after the closing bell. In the last reported quarter, the company’s earnings beat estimates by 18.52%. The bottom line ...